MedTech News
.................... by Andrew Celentano
Osteoporosis fractures fall by 94% in small first-in-human stem cell trial
Somewhere in the world, a woman over 50 will have fractured a bone by the time you finish reading this sentence due to osteoporosis, a silent bone disease that can weaken the structural integrity of the skeletal system and a person’s quality of life. The disease weakens bones and makes them more likely to break because of reduced bone mineral density and bone mass, and it affects an estimated 75 million people across Europe, the USA, and Japan.
Piezo Direct Develops Mesh Piezo Atomizer for Inhalation Applications
Safety-driven design eliminates laser-drilling debris and holds hole diameter at 2.0 microns
Powerful Medical announces FDA De Novo nod for AI ECG
Powerful Medical today announced FDA De Novo authorization for its Queen of Hearts AI ECG model.
Beta Bionics insulin patch pump scores FDA clearance
Beta Bionics (NASDAQ: BBNX) has claimed an FDA clearance for its first patch pump insulin delivery system, amid plans to roll out an updated diabetes dosing algorithm and the launch of a new CGM partnership with Senseonics.
XCath Robotics receives FDA breakthrough nod for Iris system
XCath Robotics has FDA Breakthrough Device Designation for its in-development Iris surgical robotic system for mechanical thrombectomy to treat acute ischemic stroke.
Abbott wins FDA approval for Aveir VR Mini ventricular leadless pacemaker
Abbott (NYSE: ABT) announced today that the FDA has approved the smallest version yet of its Aveir leadless pacemakers.
Retinal scans may flag atrial fibrillation four years before diagnosis
People with atrial fibrillation have signs of the condition in their retinas that can be detected as early as four years before diagnosis, according to a new study led by University College London (UCL) and Moorfields researchers.
New method explores how mitochondrial tRNA changes can reshape immune cell behavior
A research team led by UCF College of Medicine assistant professor Hung Nguyen is examining an understudied molecule within T cells as a pathway to treatments for cancers, infections and autoimmune disorders.